umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Improved clinical outcomes in patients treated with natalizumab for at least 8 years - real-world data from a Swedish national post-marketing surveillance study (IMSE 1)
Show others and affiliations
2019 (English)In: Multiple Sclerosis, ISSN 1352-4585, E-ISSN 1477-0970, Vol. 25, p. 763-764Article in journal, Meeting abstract (Other academic) Published
Place, publisher, year, edition, pages
Sage Publications, 2019. Vol. 25, p. 763-764
National Category
Neurology
Identifiers
URN: urn:nbn:se:umu:diva-164062ISI: 000485303103183OAI: oai:DiVA.org:umu-164062DiVA, id: diva2:1361967
Conference
35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, SEP 11-13, 2019, Stockholm, SWEDEN
Note

Supplement: 2 

Special Issue: SI 

Meeting Abstract: P1383

Available from: 2019-10-17 Created: 2019-10-17 Last updated: 2019-10-17Bibliographically approved

Open Access in DiVA

No full text in DiVA

Authority records BETA

Sundström, Peter

Search in DiVA

By author/editor
Sundström, Peter
By organisation
Clinical Neuroscience
In the same journal
Multiple Sclerosis
Neurology

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 3 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf